Literature DB >> 22918600

Dofetilide promotes repolarization abnormalities in perfused Guinea-pig heart.

Oleg E Osadchii1.   

Abstract

PURPOSE: Dofetilide is class III antiarrhythmic agent which prolongs cardiac action potential duration because of selective inhibition of I (Kr), the rapid component of the delayed rectifier K(+) current. Although clinical studies reported on proarrhythmic risk associated with dofetilide treatment, the contributing electrophysiological mechanisms remain poorly understood. This study was designed to determine if dofetilide-induced proarrhythmia may be attributed to abnormalities in ventricular repolarization and refractoriness.
METHODS: The monophasic action potential duration and effective refractory periods (ERP) were assessed at distinct epicardial and endocardial sites along with volume-conducted ECG recordings in isolated, perfused guinea-pig heart preparations.
RESULTS: Dofetilide was found to produce the reverse rate-dependent prolongation of ventricular repolarization, increased the steepness of action potential duration rate adaptation, and amplified transepicardial variability in electrical restitution kinetics. Dofetilide also prolonged the T peak-to-end interval on ECG, and elicited a greater prolongation of endocardial than epicardial ERP, thereby increasing transmural dispersion of refractoriness. At epicardium, dofetilide prolonged action potential duration to a greater extent than ERP, thus extending the critical interval for ventricular re-excitation. This change was associated with triangulation of epicardial action potential because of greater dofetilide-induced prolonging effect at 90 % than 30 % repolarization. Premature ectopic beats and spontaneous short-lasting episodes of monomorphic ventricular tachycardia were observed in 44 % of dofetilide-treated heart preparations.
CONCLUSIONS: Proarrhythmic potential of dofetilide in guinea-pig heart is attributed to steepened electrical restitution, increased transepicardial variability in electrical restitution kinetics, amplified transmural dispersion of refractoriness, increased critical interval for ventricular re-excitation, and triangulation of epicardial action potential.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22918600     DOI: 10.1007/s10557-012-6405-1

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  7 in total

Review 1.  Electrophysiological Mechanisms of Brugada Syndrome: Insights from Pre-clinical and Clinical Studies.

Authors:  Gary Tse; Tong Liu; Ka H C Li; Victoria Laxton; Yin W F Chan; Wendy Keung; Ronald A Li; Bryan P Yan
Journal:  Front Physiol       Date:  2016-10-18       Impact factor: 4.566

Review 2.  Electrophysiological mechanisms of long and short QT syndromes.

Authors:  Gary Tse; Yin Wah Fiona Chan; Wendy Keung; Bryan P Yan
Journal:  Int J Cardiol Heart Vasc       Date:  2016-11-26

3.  Arrhythmogenic drugs can amplify spatial heterogeneities in the electrical restitution in perfused guinea-pig heart: An evidence from assessments of monophasic action potential durations and JT intervals.

Authors:  Oleg E Osadchii
Journal:  PLoS One       Date:  2018-01-19       Impact factor: 3.240

Review 4.  In Vitro and In Silico Risk Assessment in Acquired Long QT Syndrome: The Devil Is in the Details.

Authors:  William Lee; Monique J Windley; Jamie I Vandenberg; Adam P Hill
Journal:  Front Physiol       Date:  2017-11-16       Impact factor: 4.566

5.  Antiarrhythmic effect of the Ca2+-activated K+ (SK) channel inhibitor ICA combined with either amiodarone or dofetilide in an isolated heart model of atrial fibrillation.

Authors:  Jeppe Egedal Kirchhoff; Jonas Goldin Diness; Lea Abildgaard; Majid Sheykhzade; Morten Grunnet; Thomas Jespersen
Journal:  Pflugers Arch       Date:  2016-10-08       Impact factor: 3.657

6.  Fatal arrhythmias: Another reason why doctors remain cautious about chloroquine/hydroxychloroquine for treating COVID-19.

Authors:  Ilija Uzelac; Shahriar Iravanian; Hiroshi Ashikaga; Neal K Bhatia; Conner Herndon; Abouzar Kaboudian; James C Gumbart; Elizabeth M Cherry; Flavio H Fenton
Journal:  Heart Rhythm       Date:  2020-05-29       Impact factor: 6.343

7.  Quantifying arrhythmic long QT effects of hydroxychloroquine and azithromycin with whole-heart optical mapping and simulations.

Authors:  Ilija Uzelac; Abouzar Kaboudian; Shahriar Iravanian; Jimena G Siles-Paredes; James C Gumbart; Hiroshi Ashikaga; Neal Bhatia; Robert F Gilmour; Elizabeth M Cherry; Flavio H Fenton
Journal:  Heart Rhythm O2       Date:  2021-07-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.